-
Lutathera Plus Sandostatin Boosts Outcomes in Advanced NETs
06 Mar 2024 02:56 GMT
… randomly assigned to receive Sandostatin, according to the trial’s listing on … in the group that received Sandostatin alone.
Additionally, the objective response … trial, which evaluated the drug in patients who underwent previous treatment.
READ MORE: FDA …
-
Microstructure Formation and Characterization of Long-Acting Injectable Microspheres: The Gateway to Fully Controlled Drug Release Pattern
19 Feb 2024 07:39 GMT
… after freeze-drying treatment. Freeze-dried products … Matrix. Front Bioeng Biotechnol. 2019;7:303. … surface drug distribution of octreotide acetate microspheres (Sandostatin LAR … comprehensive map of FDA-approved pharmaceutical products. Pharmaceutics. 2018;10: …
-
First targeted alpha therapy wins FDA breakthrough device designation
12 Feb 2024 16:30 GMT
The US Food and Drug Administration (FDA) has granted breakthrough device designation … ) and an ongoing Phase II trial (NCT05153772), investigating the therapy in … marketed as Sandostatin.
GlobalData is the parent company of Clinical Trials Arena …
-
News24 Business | Aspen bulks up footprint in China with nearly R2bn acquisition of drug portfolio
04 Dec 2023 09:36 GMT
SA's biggest pharmaceutical group, Aspen Pharmacare, has … a portfolio of products, including Sandostatin, which treats hormonal disorders; … the performance of these drugs. The transaction still needs … Join our free subscription trial to unlock this story …
-
What medications are available for pituitary tumors?
28 Feb 2023 17:56 GMT
… . Doctors usually recommend them as injectable long-acting drugs. Examples include:
octreotide (Sandostatin … removal is the treatment of choice, not medication. Sometimes, a doctor may recommend …
-
Motility disorders and their treatments
17 Feb 2023 16:44 GMT
… asthma medicines, nonsteroidal anti-inflammatory drugs, and tricyclic antidepressants
Treatment for … cases, a doctor may recommend surgery.
Doctors sometimes call … Treatments for the condition include:
dietary changes
medicines, such as octreotide (Sandostatin …
-
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS
13 Jan 2023 03:49 GMT
… of care as first-line medical treatment.
- Debiopharm is developing … -year long phase 1b trial, we look forward to … available as immediate-release (Sandostatin®) and 4-week long … efficacy, and then select pharmaceutical commercialization partners to maximize …
-
July - September 2022 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
03 Jan 2023 15:11 GMT
… FDA is evaluating the need for regulatory action.
Lanreotide
Mycapssa (octreotide)
Sandostatin … (octreotide acetate)
Sandostatin LAR Depot (octreotide …
Risk of wrong drug medication errors associated with look- …
-
Full list of medicines affected as Ireland faces major shortages
11 Jan 2023 06:43 GMT
… 2023 Amorolfine 5%w/v Medicated Nail Lacquer
PA0711/ …
9th January 2023 Benylin Cough Medicine Syrup
PA0330/019… June 2022 Flector Tissugel 140mg Medicated Plaster
PA1104/004…
4th January 2023
HCP letter
Sandostatin 500mcg/ml, Solution …
-
Lutathera Shows Promise as Part of Initial Therapy for Some Neuroendocrine Tumors
01 Mar 2024 15:56 GMT
… 177-dotatate plus octreotide (Sandostatin) lived almost three times … the Food and Drug Administration (FDA) for the treatment of advanced … Medical Center during a discussion of the NETTER-2 trial … their initial treatment if they and their doctor agree it …